Dr. Alexandra Papaioannou, BScN, MD, MSc, FRCPC, FACP
Professor, Division of Geriatric Medicine, Department of Medicine, McMaster University
Chairholder, CIHR - Eli Lilly Canada Chair in Osteoporosis
Associate Member, Centre for Evaluation of Medicines
Dr. Alexandra Papaioannou is a Professor in the Department of Medicine, and past Director of the Division of Geriatric Medicine at McMaster University with joint appointment in the Division of Rheumatology. She has received a CIHR - Eli Lilly Osteoporosis and Fracture Prevention Chair. She is an Associate Member in the Department of Clinical Epidemiology and Biostatistics and has completed Masters of Science (MSc), Health Research Methods at McMaster University. Dr. Papaioannou was previously Chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and the former Chair of the Board. Dr. Papaioannou was awarded the Lindy Fraser Award (2005) by OC. She is Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos) and is leading the Fracture Think Osteoporosis project, a chronic disease management program in Hamilton, Ontario. Dr. Papaioannou is a member of the Scientific Advisors of the International Osteoporosis Foundation.
Dr. Papaioannou is lead author of newly published Osteoporosis Canada guidelines which were published in the October 2010 issue of the Canadian Medical Association Journal (CMAJ). She was awarded an Ontario Career Scientist Award and has served on a number of Ontario Ministry of Health and Long Term Care (MOH LTC) Committees including serving as the Co-Chair of the MOH LTC Osteoporosis Strategy for Ontario, a public health initiative to prevent and reduce the impact of osteoporosis, fractures and falls. She is lead investigator for the Long-term Care Ontario Osteoporosis Strategy.
She has served on CIHR committees including Scientific Officer of the Mobility in Aging - Pilot Project Committee. Dr. Papaioannou has received a number of CIHR grants including "Improving Prescribing of Medications and Patient Safety in Long-Term Care" and has been a co-investigator of a number of team CIHR grants: "Helping seniors and primary care professionals optimize the use of drugs to improve health (TIPPS)", and "Training program in skeletal health research". Dr. Papaioannou is an Associate Member of the Centre for Evaluation of Medicines, St. Joseph's Healthcare, and a Geriatrician at Hamilton Health Sciences. Dr. Papaioannou is author on 14 book chapters and over 140 journal articles.
Dr. Papaioannou is currently the primary supervisor for Janet Pritchard, PhD Candidate in Medical Sciences at McMaster University. Their research interests involve using novel modalities, such as MRI, to investigate the impact of type 2 diabetes on bone quality.